Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply

Carlsson Sigrid V.; Albertsen Peter C.

首页> 外文期刊>European urology >Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply

【24h】

Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply

机译：与临床诊断相比，经筛查发现的前列腺癌的治愈性治疗后生存率更高：是真正的效果还是提前期偏倚？回复

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2015年第2期|共2页
作者
Carlsson Sigrid V.; Albertsen Peter C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
入库时间 2022-08-18 10:59:33

相似文献

外文文献
中文文献
专利

1. Reply from Authors re: Sigrid V. Carlsson, Peter C. Albertsen. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Eur Urol 2015; 68: 183-4 Better Treatment in the Control Arm of the ERSPC Rotterdam: A Point Worth Noting? [J] . Bokhorst Leonard P., Roobol Monique J., Kranse Ries European urology . 2015,第2期

机译：作者的回复：Sigrid V. Carlsson，Peter C. Albertsen。与临床诊断相比，经筛查发现的前列腺癌的治愈性治疗后生存率更高：是真正的效果还是提前期偏倚？欧元2015年; 68：183-4在鹿特丹ERSPC的控制臂中进行更好的治疗：值得注意吗？
2. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply [J] . Carlsson Sigrid V., Albertsen Peter C. European urology . 2015,第2期

机译：与临床诊断相比，经筛查发现的前列腺癌的治愈性治疗后生存率更高：是真正的效果还是提前期偏倚？回复
3. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply [J] . Carlsson Sigrid V., Albertsen Peter C. European urology . 2015,第2期

机译：与临床诊断相比，经筛查发现的前列腺癌的治愈性治疗后生存率更高：是真正的效果还是提前期偏倚？回复
4. Classification Models and Survival Analysis for Prostate Cancer Using RNA Sequencing and Clinical Data [C] . Md Faisal Kabir, Simone A. Ludwig IEEE International Conference on Big Data . 2019

机译：RNA测序和临床数据对前列腺癌的分类模型和生存分析
5. Soy isoflavone supplementation and biochemical recurrence after curative treatment for localized prostate cancer. [D] . Camey, Sarah C. 2013

机译：大豆异黄酮的补充和治疗后的局限性前列腺癌的生化复发。
6. The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer [O] . Paul A Blood, Tom Pickles 2007

机译：被选为前列腺癌并接受根治性放射治疗的80岁以下男性的非前列腺癌中位生存期超过10年
7. The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer [O] . Pickles Tom, Blood Paul A 2007

机译：被选为前列腺癌并接受根治性放射治疗的80岁以下男性的非前列腺癌中位生存期超过10年

Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply

著录项

相似文献

相关主题

期刊订阅